Tilapia lake virus (TiLV) is an emerging disease of cultured tilapia in the Asia-Pacific region. Originally observed and reported in Israel, Ecuador, Colombia and Egypt, TiLV is now confirmed in cultured tilapia in Thailand causing mass mortalities. At risk is here is the US$7.5 billion global industry per annum, especially among the top tilapia-producing countries in the region including China, the Philippines, Thailand, Indonesia, Lao PDR and Bangladesh. This advisory describes signs of the disease and PCR detection methods.
In this issue:
Anti-microbial resistance in aquaculture; participatory market chain approaches to boost fish nurseries; traditional community fishing practices of rural Assam; practical significance of restricted feeding regimes in aquaculture; Bangana dero: A potential indigenous fish species for diversification of carp culture; shell colour variation in farmed Litopenaeus vannamei: Comparison of white- and brown-shelled shrimp; culture-based fisheries: A low-tech, greenhouse friendly approach to improving food and income for Cambodian families.
In this issue:
The 15th meeting of the Asia Regional Advisory Group on Aquatic Animal Health; a regional consultation on responsible production and use of feed in aquaculture; a report on the Giant Prawn 2017 conference; a preview of the new NACA website; and new initiatives on a very serious emerging issue - reducing the human and animal health risks from development of anti-microbial resistance in the aquaculture industry.
Tilapia lake virus (TiLV) is an emerging virus that causes syncytial hepatitis of tilapia with mortalities of up to 90%. Recent disease outbreaks in Thai tilapia farms have been associated with high cumulative mortalities and histopathological features typical of SHT. Infection has now been confirmed. The semi-nested RT-PCR protocol described here may be used freely for non-commercial applications to detect TiLV. The authors urge laboratories in Asia to test for TiLV when abnormal tilapia mortality occurs.
The development of resistant strains of disease-causing microorganisms is an important health issue of global concern. When microbes such as bacteria, fungi, parasites, and viruses become resistant to antimicrobial substances, the diseases they may cause become more difficult or impossible to treat. Resistance is developed by the indiscriminate use of antimicrobials and places human health at risk. The discovery of antibiotics revolutionised medicine, creating a belief that a 'magic bullet' had finally been found to control bacterial diseases. Antibiotics, a class of antimicrobial agents, kill or inhibit the growth of bacteria, but they have no significant effect on other types of microorganisms such as viruses.